Md. Ahad Ali

About

Medicinal Chemistry | Drug Discovery | Immunology | Biotechnology

B.Sc. & M.Sc. (Organic) in Chemistry
University of Rajsahahi
Rajshahi Bangladesh

Employment

• The University of Texas at El Paso Teaching Assistant
  2026 - Present
• Panacea Research Center (PRC), Bangladesh Founder and Project Coordinator
  2023 - Present
• Bioinformatics Labotory (Dry) Research Assistant
  2022 - Present
• Polymer Colloids and Nanomaterials (PCN) Laboratory Gradauate Reseach Student
  2022 - 2024
• Rajshahi University Science Club Joint- Secretary
  2020 - 2021
• Rajshahi University Science Club Publicity Secretary
  2019 - 2020

Education

• The University of Texas at El Paso PhD Student
  2026 - Present
• University of Rajshahi Master of Science
  2022 - 2024
• University of Rajshahi Bachelor of Science
  2017 - 2022

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• Identification of multi-transcriptomic prognostic biomarkers to explore natural therapeutics for lung cancer integrating machine learning
  Digital Discovery 2026 DOI: 10.1039/D6DD00045B
  +Save
• Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach
  PLOS One 2026 DOI: 10.1371/journal.pone.0350614
  +Save
• Identification of plant-derived secondary metabolites as potential CDK2 inhibitors against colorectal cancer: Molecular docking, dynamics simulations and DFT study
  Letters in Drug Design & Discovery 2025 DOI: 10.1016/j.lddd.2026.100318
  +Save
• Kaempferols from Echinacea purpurea demonstrate anti-cancer potential by targeting anexelekto in breast cancer therapy using chemoinformatics approach
  Discover Oncology 2025 DOI: 10.1007/s12672-025-03541-9
  +Save
• Common molecular links and therapeutic insights between type 2 diabetes and kidney cancer
  PLOS One 2025 DOI: 10.1371/journal.pone.0330619
  +Save
• discovery of type-2 diabetes-causing host key genes that are associated with the complexity of monkeypox and repurposing common drugs
  Briefings in Bioinformatics 2025 DOI: 10.1093/bib/bbaf215
  +Save
• Designing a multi-epitope vaccine candidate against human rhinovirus C utilizing immunoinformatics approach
  Frontiers in Immunology 2025 DOI: 10.3389/fimmu.2024.1364129
  +Save
• Multi-omics pan-cancer profiling of CDK2 and in silico identification of plant-derived inhibitors using machine learning approaches
  RSC Advances 2025 DOI: 10.1039/D5RA05535K
  +Save
• Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma
  PLOS ONE 2024 DOI: 10.1371/journal.pone.0310843
  +Save
• Discovery of Bacterial Key Genes from 16S rRNA-Seq Profiles That Are Associated with the Complications of SARS-CoV-2 Infections and Provide Therapeutic Indications
  Pharmaceuticals 2024 DOI: 10.3390/ph17040432
  +Save